362 related articles for article (PubMed ID: 27209063)
1. High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
Adeel AA; Elnour FA; Elmardi KA; Abd-Elmajid MB; Elhelo MM; Ali MS; Adam MA; Atta H; Zamani G; Warsame M; Barrette A; Mohammady HE; Nada RA
Malar J; 2016 May; 15(1):285. PubMed ID: 27209063
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Warsame M; Hassan AH; Hassan AM; Arale AM; Jibril AM; Mohamud SA; Barrette A; Muse AY; Yusuf FE; Nada RA; Amran JG
Trop Med Int Health; 2017 Apr; 22(4):415-422. PubMed ID: 28151566
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK
Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538
[TBL] [Abstract][Full Text] [Related]
4. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
[TBL] [Abstract][Full Text] [Related]
5. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
6. A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India.
Srivastava P; Ratha J; Shah NK; Mishra N; Anvikar AR; Sharma SK; Das MK; Srivastava B; Valecha N
Malar J; 2013 Jul; 12():247. PubMed ID: 23866298
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the efficacy of antimalarial medicines in India via sentinel sites: Outcomes and risk factors for treatment failure.
Mishra N; Srivastava B; Bharti RS; Rana R; Kaitholia K; Anvikar AR; Das MK; Ghosh SK; Bhatt RM; Tyagi PK; Dev V; Phookan S; Wattal SL; Sonal GS; Dhariwal AC; Valecha N
J Vector Borne Dis; 2016; 53(2):168-78. PubMed ID: 27353588
[TBL] [Abstract][Full Text] [Related]
8. Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.
Warsame M; Hassan AM; Barrette A; Jibril AM; Elmi HH; Arale AM; Mohammady HE; Nada RA; Amran JG; Muse A; Yusuf FE; Omar AS
Trop Med Int Health; 2015 Apr; 20(4):510-7. PubMed ID: 25583123
[TBL] [Abstract][Full Text] [Related]
9. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.
Mukhtar EA; Gadalla NB; El-Zaki SE; Mukhtar I; Mansour FA; Babiker A; El-Sayed BB
Malar J; 2007 Jul; 6():92. PubMed ID: 17631681
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007-2015): In vivo response and dhfr and dhps mutations.
Kakar Q; Sheikh S; Ahmed I; Khan MA; Jamil M; ElMohammady H; Warsame M
Acta Trop; 2016 Dec; 164():17-22. PubMed ID: 27515812
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India.
Bharti PK; Shukla MM; Ringwald P; Krishna S; Singh PP; Yadav A; Mishra S; Gahlot U; Malaiya JP; Kumar A; Prasad S; Baghel P; Singh M; Vadadi J; Singh MP; Bustos MD; Ortega LI; Christophel EM; Kashyotia SS; Sonal GS; Singh N
Malar J; 2016 Oct; 15(1):498. PubMed ID: 27737665
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
13. Molecular Evidence for
Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP
Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.
Niaré K; Dara A; Sagara I; Sissoko MS; Guindo CO; Cissé NH; Coulibaly CO; Ringwald P; Benoit-Vical F; Berry A; Djimdé AA; Doumbo OK
Am J Trop Med Hyg; 2016 Mar; 94(3):634-9. PubMed ID: 26811430
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.
Awab GR; Imwong M; Pukrittayakamee S; Alim F; Hanpithakpong W; Tarning J; Dondorp AM; Day NP; White NJ; Woodrow CJ
Malar J; 2016 Feb; 15():121. PubMed ID: 26917051
[TBL] [Abstract][Full Text] [Related]
17. The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.
Malisa AL; Pearce RJ; Mutayoba BM; Abdullah S; Mshinda H; Kachur PS; Bloland P; Roper C
Malar J; 2011 Oct; 10():317. PubMed ID: 22029848
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
[TBL] [Abstract][Full Text] [Related]
19. Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.
Gadalla NB; Abdallah TM; Atwal S; Sutherland CJ; Adam I
Malar J; 2013 Jul; 12():255. PubMed ID: 23870667
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of malaria in Cameroon. XXX. sequence analysis of Plasmodium falciparum ATPase 6, dihydrofolate reductase, and dihydropteroate synthase resistance markers in clinical isolates from children treated with an artesunate-sulfadoxine-pyrimethamine combination.
Menemedengue V; Sahnouni K; Basco L; Tahar R
Am J Trop Med Hyg; 2011 Jul; 85(1):22-5. PubMed ID: 21734119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
